Chief Operating Officer, Rivus Pharmaceuticals, Inc.

Allen Cunningham

Rivus Pharmaceuticals

Chief Medical Officer

Consultant

Head of Therapeutics

Senior Research Physician

Chief Medical Officer @ Rivus Pharmaceuticals | MD, MPH

Robert Schott

Chief Executive Officer

Member Board of Directors

Executive Chairman

Member Board Of Directors

President and CEO

Chief Executive Officer at Rivus Pharmaceuticals

Jayson Dallas

Executive Business Partner

Senior Executive Assistant

Chief of Staff

Global Program Manager

Senior Administrative Assistant

Administrative Assistant

Executive Business Partner at Rivus

Brittany Chmielewski

Senior Director & Controller

Biotech and Pharmaceutical Accounting Consultant

Vice President, Finance And Administration

Senior Director Finance Capital Projects & Corporate Affairs (NASDAQ-FOLD)

Vice President Of Finance And Operations

Corporate Controller

Assistant Controller

Biotech and Pharmaceutical Finance & Accounting Professional

Mariam Faragalla

Director, IP

Licensing Associate

Research Instructor

Postdoctoral Fellow

Graduate Student

IP protection and Business Development

Mikael Herlevsen

Director of Development

Senior Scientist

Post-Doctoral fellow

Post-Doctoral Fellow

Jameel Dennis

Rivus Pharmaceuticals is a biotechnology company focused on developing innovative therapies for the treatment of rare and infectious diseases.

Rivus Pharmaceuticals, Inc., is dedicated to transforming the treatment of cardio-metabolic disease by advancing a new class of oral, once daily, small molecule therapeutics called Controlled Metabolic Accelerators (CMAs). Rivus’ CMAs are designed to improve cellular metabolism and treat the underlying cause of highly prevalent metabolic and cardiovascular diseases including type 2 diabetes, severe hypertriglyceridemia (SHTG), non-alcoholic steatohepatitis (NASH), as well as cardiovascular diseases such as heart failure with reduced ejection fraction (HFpEF). For more information please visit https://www.rivuspharma.com/

RxCapital

Longitude Capital

Medicxi

Bain Capital Life Sciences

BB Biotech Ventures

RA Capital Management